David Moher

Research interests

Publications

• CONSORT 2025 statement: updated guideline for reporting randomised trials

  BMJ · 2025 · https://doi.org/10.1136/bmj-2024-081123

• Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement

  BMJ · 2022 · https://doi.org/10.1136/bmj-2022-070849

• Guidelines for Reporting Outcomes in Trial Reports

  JAMA · 2022 · https://doi.org/10.1001/jama.2022.21022

• The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

  BMJ · 2021 · https://doi.org/10.1136/bmj.n71

• PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews

  Systematic Reviews · 2021 · 10.1186/s13643-020-01542-z

• Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement

  Journal of Clinical Epidemiology · 2021 · 10.1016/j.jclinepi.2021.02.003

• The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

  International Journal of Surgery · 2021 · https://doi.org/10.1016/j.ijsu.2021.105906

• Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas

  Revista Española de Cardiología · 2021 · 10.1016/j.recesp.2021.06.016

• PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews

  BMJ · 2021 · https://doi.org/10.1136/bmj.n160

• Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension

  Nature Medicine · 2020 · 10.1038/s41591-020-1037-7

• Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension

  Nature Medicine · 2020 · 10.1038/s41591-020-1037-7

• Preferred reporting items for systematic review and meta-analysis of diagnostic test accuracy studies (PRISMA-DTA): explanation, elaboration, and checklist

  BMJ · 2020 · 10.1136/bmj.m2632

• Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension

  Nature Medicine · 2020 · 10.1038/s41591-020-1034-x

• PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation

  Annals of Internal Medicine · 2018 · https://doi.org/10.7326/m18-0850

• Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies

  JAMA · 2018 · 10.1001/jama.2017.19163

• CARE guidelines for case reports: explanation and elaboration document

  Journal of Clinical Epidemiology · 2017 · 10.1016/j.jclinepi.2017.04.026

• CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts

  Annals of Internal Medicine · 2017 · 10.7326/m17-0046

• AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both

  BMJ · 2017 · 10.1136/bmj.j4008

• Epidemiology and Reporting Characteristics of Systematic Reviews of Biomedical Research: A Cross-Sectional Study

  PLoS Medicine · 2016 · 10.1371/journal.pmed.1002028

• The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement

  PLoS Medicine · 2015 · 10.1371/journal.pmed.1001885

• Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement

  Systematic Reviews · 2015 · 10.1186/2046-4053-4-1

• Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

  BMJ · 2015 · 10.1136/bmj.g7647

• The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations

  Annals of Internal Medicine · 2015 · 10.7326/m14-2385

• STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies

  BMJ · 2015 · 10.1136/bmj.h5527

• STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies

  Radiology · 2015 · 10.1148/radiol.2015151516

• STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies

  Clinical Chemistry · 2015 · 10.1373/clinchem.2015.246280

• A scoping review of rapid review methods

  BMC Medicine · 2015 · 10.1186/s12916-015-0465-6

• Reducing waste from incomplete or unusable reports of biomedical research

  The Lancet · 2014 · 10.1016/s0140-6736(13)62228-x

• Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide

  BMJ · 2014 · 10.1136/bmj.g1687

• Scoping reviews: time for clarity in definition, methods, and reporting

  Journal of Clinical Epidemiology · 2014 · 10.1016/j.jclinepi.2014.03.013

• Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force

  Value in Health · 2013 · 10.1016/j.jval.2013.02.002

• Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement

  BMJ · 2013 · 10.1136/bmj.f1049

• SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials

  Annals of Internal Medicine · 2013 · 10.7326/0003-4819-158-3-201302050-00583

• Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement

  Value in Health · 2013 · 10.1016/j.jval.2013.02.010

• Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials

  Annals of Internal Medicine · 2012 · 10.7326/0003-4819-157-6-201209180-00537

• The nuts and bolts of PROSPERO: an international prospective register of systematic reviews

  Systematic Reviews · 2012 · 10.1186/2046-4053-1-2

• PRISMA-Equity 2012 Extension: Reporting Guidelines for Systematic Reviews with a Focus on Health Equity

  PLoS Medicine · 2012 · 10.1371/journal.pmed.1001333

• CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials

  International Journal of Surgery · 2011 · 10.1016/j.ijsu.2011.10.001

• Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

  BMJ · 2011 · 10.1136/bmj.d4002

• The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

  BMJ · 2011 · 10.1136/bmj.d5928

• CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials

  BMC Medicine · 2010 · 10.1186/1741-7015-8-18

• Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

  International Journal of Surgery · 2010 · 10.1016/j.ijsu.2010.02.007

• CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials

  BMJ · 2010 · 10.1136/bmj.c869

• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.

  PubMed · 2009

• The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

  Annals of Internal Medicine · 2009 · 10.7326/0003-4819-151-4-200908180-00136

• The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

  Journal of Clinical Epidemiology · 2009 · 10.1016/j.jclinepi.2009.06.006

• The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

  BMJ · 2009 · 10.1136/bmj.b2700

• The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

  PLoS Medicine · 2009 · 10.1371/journal.pmed.1000100

• Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

  PLoS Medicine · 2009 · https://doi.org/10.1371/journal.pmed.1000097

• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

  BMJ · 2009 · https://doi.org/10.1136/bmj.b2535

• STrengthening the REporting of Genetic Association Studies (STREGA)— An Extension of the STROBE Statement

  PLoS Medicine · 2009 · 10.1371/journal.pmed.1000022

• Extending the CONSORT Statement to Randomized Trials of Nonpharmacologic Treatment: Explanation and Elaboration

  Annals of Internal Medicine · 2008 · 10.7326/0003-4819-148-4-200802190-00008

• Improving the reporting of pragmatic trials: an extension of the CONSORT statement

  BMJ · 2008 · 10.1136/bmj.a2390

• Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews

  BMC Medical Research Methodology · 2007 · 10.1186/1471-2288-7-10

• Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy.

  PubMed · 2003 · 10.1373/49.1.1

• Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses?

  The Lancet · 2000 · 10.1016/s0140-6736(00)02786-0

• Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

  The Lancet · 1998 · 10.1016/s0140-6736(98)01085-x

• Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews

  The Lancet · 1996 · 10.1016/s0140-6736(96)90538-3

• Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists

  Controlled Clinical Trials · 1995 · 10.1016/0197-2456(94)00031-w

Current projects

No projects listed.